Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathella Pavan Kumar

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Plos Pathogens|September 12, 2014
Helminth infections coincident with active pulmonary tuberculosis inhibit mono- and multifunctional CD4+ and CD8+ T cell responses in a process dependent on IL-10Parakkal Jovvian George, Rajamanickam Anuradha, Nathella Pavan Kumar, et al.
Frontiers in Immunology|March 29, 2020
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary TuberculosisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Cytokine|June 7, 2018
Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Plos One|March 2, 2013
Expansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitisNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Frontiers in Immunology|February 27, 2026
Complement profiling for treatment outcomes in pulmonary TBNathella Pavan Kumar, Arul Nancy P, Syed Hissar, et al.
BMC Infectious Diseases|December 11, 2019
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapyNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Frontiers in Immunology|December 6, 2021
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment FailureNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Immunology|June 23, 2015
Profiling leucocyte subsets in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Sharmila D Dhakshinraj, et al.
Tuberculosis (Edinburgh, Scotland)|July 17, 2014
Altered CD8(+) T cell frequency and function in tuberculous lymphadenitisNathella Pavan Kumar, Rathinam Sridhar, Luke Elizabeth Hanna, et al.
Annals of the American Thoracic Society|August 31, 2013
Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokinesNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Plos Pathogens|September 12, 2014
Helminth infections coincident with active pulmonary tuberculosis inhibit mono- and multifunctional CD4+ and CD8+ T cell responses in a process dependent on IL-10Parakkal Jovvian George, Rajamanickam Anuradha, Nathella Pavan Kumar, et al.
Frontiers in Immunology|March 29, 2020
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary TuberculosisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Cytokine|June 7, 2018
Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Plos One|March 2, 2013
Expansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitisNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Frontiers in Immunology|February 27, 2026
Complement profiling for treatment outcomes in pulmonary TBNathella Pavan Kumar, Arul Nancy P, Syed Hissar, et al.
BMC Infectious Diseases|December 11, 2019
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapyNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Frontiers in Immunology|December 6, 2021
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment FailureNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Immunology|June 23, 2015
Profiling leucocyte subsets in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Sharmila D Dhakshinraj, et al.
Tuberculosis (Edinburgh, Scotland)|July 17, 2014
Altered CD8(+) T cell frequency and function in tuberculous lymphadenitisNathella Pavan Kumar, Rathinam Sridhar, Luke Elizabeth Hanna, et al.
Annals of the American Thoracic Society|August 31, 2013
Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokinesNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Pageof 10